{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:41:29Z","timestamp":1773283289128,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ijmm.2017.04.003","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T21:47:58Z","timestamp":1492638478000},"page":"216-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004\u20132005 to 2014\u20132015"],"prefix":"10.1016","volume":"307","author":[{"given":"Julia","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Al-Lahham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Levina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias W.","family":"Pletz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Im\u00f6hl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmm.2017.04.003_bib0005","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/jac\/dkh147","article-title":"An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae","volume":"53","author":"Alonso","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0010","first-page":"93","article-title":"Pneumococcal conjugate vaccine for childhood immunization\u2013WHO position paper","volume":"82","author":"WHO","year":"2007","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0015","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper\u20132012","volume":"87","author":"WHO","year":"2012","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/clinids\/3.2.183","article-title":"Pneumococcus: the first one hundred years","volume":"3","author":"Austrian","year":"1981","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0025","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1128\/AAC.47.7.2072-2081.2003","article-title":"Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae","volume":"47","author":"Balsalobre","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0030","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1128\/AAC.41.6.1396","article-title":"Apparent involvement of a multidrug transporter in the fluoroquinolone resistance of Streptococcus pneumoniae","volume":"41","author":"Baranova","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0035","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1128\/AAC.44.11.3049-3054.2000","article-title":"Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance","volume":"44","author":"Bast","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0040","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1128\/AAC.47.12.3815-3824.2003","article-title":"Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents","volume":"47","author":"Browne","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0045","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/AAC.46.3.680-688.2002","article-title":"Fluoroquinolone resistance in streptococcus pneumoniae in United States since 1994\u20131995","volume":"46","author":"Brueggemann","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0050","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of streptococcus pneumoniae to fluoroquinolones in Canada: canadian bacterial surveillance network","volume":"341","author":"Chen","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0055","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1128\/AAC.48.5.1699-1707.2004","article-title":"Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy","volume":"48","author":"Croisier","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0060","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMoa012122","article-title":"Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia","volume":"346","author":"Davidson","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0065","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1128\/AAC.02669-13","article-title":"Fluoroquinolone-resistant pneumococci: dynamics of serotypes and clones in Spain in 2012 compared with those from 2002 and 2006","volume":"58","author":"Domenech","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1128\/.61.3.377-392.1997","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"Pt. 11","key":"10.1016\/j.ijmm.2017.04.003_bib0075","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1099\/00221287-144-11-3049","article-title":"A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease","volume":"144","author":"Enright","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.ijmm.2017.04.003_bib0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1054\/drup.1998.0068","article-title":"Mechanisms of fluoroquinolone resistance","volume":"2","author":"Hooper","year":"1999","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ijmm.2017.04.003_bib0085","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1128\/AAC.46.8.2712-2715.2002","article-title":"Topoisomerase mutations associated with in vitro selection of resistance to moxifloxacin in Streptococcus pneumoniae","volume":"46","author":"Houssaye","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0090","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2165\/00003495-200262140-00013","article-title":"Levofloxacin: an updated review of its use in the treatment of bacterial infections","volume":"62","author":"Hurst","year":"2002","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.ijmm.2017.04.003_bib0095","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ijmm.2015.08.031","article-title":"Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany","volume":"305","author":"Im\u00f6hl","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0100","series-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-fifth Informational Supplement M100-S25","author":"Clinical Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.ijmm.2017.04.003_bib0105","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/JCM.44.3.970-975.2006","article-title":"Rapid screening of fluoroquinolone resistance determinants in Streptococcus pneumoniae by PCR-restriction fragment length polymorphism and single-strand conformational polymorphism","volume":"44","author":"Ip","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1128\/AAC.44.2.462-466.2000","article-title":"Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997\u20131998 respiratory season","volume":"44","author":"Jones","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0115","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diagmicrobio.2012.08.024","article-title":"Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998\u20132011)","volume":"75","author":"Jones","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/AAC.50.1.310-317.2006","article-title":"Quinolone efflux pumps play a central role in emergence of fluoroquinolone resistance in Streptococcus pneumoniae","volume":"50","author":"Jumbe","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0125","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1128\/AAC.40.10.2252","article-title":"ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype","volume":"40","author":"Munoz","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jiac.2014.07.014","article-title":"Twelve-year survey (2001\u20132012) of the antimicrobial susceptibility of Streptococcus pneumoniae isolates from otorhinolaryngology clinics in Miyagi Prefecture, Japan","volume":"20","author":"Ozawa","year":"2014","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0135","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/AAC.40.10.2321","article-title":"Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae","volume":"40","author":"Pan","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0140","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/AAC.48.9.3491-3497.2004","article-title":"Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10096-004-1254-x","article-title":"Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy","volume":"24","author":"Pletz","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1128\/AAC.49.2.779-780.2005","article-title":"Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States","volume":"49","author":"Pletz","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0155","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1128\/AAC.50.4.1561-1563.2006","article-title":"Prevalence of first-step mutants among levofloxacin-susceptible invasive isolates of Streptococcus pneumoniae in the United States","volume":"50","author":"Pletz","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijmm.2010.05.004","article-title":"Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage","volume":"301","author":"Pletz","year":"2011","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0165","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ijmm.2013.02.014","article-title":"Antihypertensives suppress the emergence of fluoroquinolone-resistant mutants in pneumococci: an in vitro study","volume":"303","author":"Pletz","year":"2013","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0170","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1128\/AAC.00250-11","article-title":"International pneumococcal clones match or exceed the fitness of other strains despite the accumulation of antibiotic resistance","volume":"55","author":"Rudolf","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0175","doi-asserted-by":"crossref","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","article-title":"Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany","volume":"10","author":"van der Linden","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijmm.2017.04.003_bib0180","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200012283432603","article-title":"Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States","volume":"343","author":"Whitney","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0185","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1093\/jac\/dkv134","article-title":"Insights into the evolutionary trajectories of fluoroquinolone resistance in Streptococcus pneumoniae","volume":"70","author":"Zhang","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijmm.2017.04.003_bib0190","first-page":"18","article-title":"Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012","volume":"38","author":"Zhao","year":"2015","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422116304271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422116304271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T22:04:41Z","timestamp":1601935481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422116304271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":38,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S1438422116304271"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2017.04.003","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolone resistance in Streptococcus pneumoniae isolates in Germany from 2004\u20132005 to 2014\u20132015","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2017.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}]}}